MASS
908 Devices Inc.
NASDAQ · USHealthcareMedical - Devices
$7.03-4.35%
Price as of Jul 20, 2026
MASS profitability
908 Devices Inc. profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 49.0%
- EBITDA margin
- -46.0%
- EBIT margin
- -52.5%
- Net margin
- -62.1%
- Free cash flow margin
- -14.6%
Returns
- Return on equity
- -26.8%
- Return on assets
- -19.2%
- Return on invested capital
- -21.9%
- Asset turnover
- 0.31x
Cash efficiency
- Cash from operations
- -$7.6M
- Cash per share
- $2.96
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.